Delivering Innovative Biomarker Solutions That Meet or Exceed Your Needs
Clinical research benefits from innovative biomarker solutions that deploy a broad range of technology, methodologies, and matrices to test for novel biomarkers. Our comprehensive biomarker approach helps you ensure both the clinical and commercial success of your drug candidate in an efficient and cost-effective manner.
Cambridge Biomedical has significant experience working with large and small molecules, biologics, vaccines, and biomarkers to support pharmaceutical, biotech, and in vitro diagnostic (IVD) manufacturing companies across the development cycle.
Our Areas of Expertise:
With established expertise in assay development, assay validation, and sample testing for biomarkers and bio assays, we provide a diverse range of simple to highly complex assays for both routine and esoteric use, across a wide range of technologies. We also accommodate study sizes with low-, medium-, or high-volume sample testing requirements.
Our laboratory is CLIA-certified, CAP-accredited, and GLP/GCLP-compliant.